Skip to main content
. 2014 Feb 9;4(1):27–35. doi: 10.1007/s13659-014-0004-8

Table 1.

Cell length and aspect ratio relative to control for natural products

Natural product and trial number L/Lca (%) AR/ARcb (%) Mean L/Lc (%) Mean AR/ARc (%)
Khellin
 Trial 1 121.7 94.1 114.7 ± 9.2 97.5 ± 8.0
 Trial 2 112.6 101.6
 Trial 3 109.7 96.6
Artemisinine
 Trial 1 101.0 106.8 103.9 ± 3.6 106.0 ± 2.1
 Trial 2 106.0 106.5
 Trial 3 104.8 104.7
Beta-lapachone
 Trial 1 103.7 98.6 102.9 ± 5.3 98.9 ± 3.9
 Trial 2 100.4 99.3
 Trial 3 104.7 98.9
Lonchocarpic acid
 Trial 1 102.7 109.5 101.4 ± 2.8 111.5 ± 2.7
 Trial 2 101.5 112.0
 Trial 3 99.9 113.0
Castanospermine
 Trial 1 99.9 100.3 101.0 ± 4.8 98.9 ± 4.5
 Trial 2 100.9 100.3
 Trial 3 102.0 96.3
Curcumin
 Trial 1 101.4 103.9 100.5 ± 5.0 101.6 ± 4.5
 Trial 2 101.9 99.8
 Trial 3 98.2 101.0
Glaucarubine
 Trial 1 92.6 102.5 98.1 ± 6.6 100.9 ± 4.3
 Trial 2 101.2 101.2
 Trial 3 100.5 99.2
Triptolide
 Trial 1 97.3 101.5 98.0 ± 5.8 99.3 ± 7.5
 Trial 2 98.5 96.9
 Trial 3 98.1 99.6
Parthenolide
 Trial 1 103.4 89.6 98.0 ± 4.9 91.4 ± 2.8
 Trial 2 94.6 91.8
 Trial 3 95.9 92.7
Michellamine B
 Trial 1 94.5 90.3 97.0 ± 2.5 92.9 ± 3.4
 Trial 2 98.0 95.1
 Trial 3 98.5 93.3
Tetrocarcin A
 Trial 1 96.2 99.7 96.7 ± 1.6 99.4 ± 2.7
 Trial 2 95.9 100.2
 Trial 3 98.0 98.2
Bactobolin
 Trial 1 95.7 99.3 92.2 ± 6.3 97.6 ± 2.9
 Trial 2 95.8 97.2
 Trial 3 85.0 96.4
Phleomycin [7] 157.9 ± 17.5 64.6 ± 13.1

aL/Lc = mean length of NP-exposed cells divided by mean length of control cells (not exposed to NP), as a percentage. Both NP-exposed and control measurements were performed in triplicate

bAR/ARc = mean aspect ratio of NP-exposed cells divided by mean length of control cells (not exposed to NP), as a percentage